Relapsing optic neuritis and meningoencephalitis in a child: Case report of delayed diagnosis of MOG-IgG syndrome

Xiaonan Zhong, Yanyu Chang, Sha Tan, Jingqi Wang, Xiaobo Sun, Aimin Wu, Lisheng Peng, Alexander Y. Lau, Allan G. Kermode, Wei Qiu

Research output: Contribution to journalArticle

Abstract

Background: Recurrent optic neuritis (ON) was previously thought to be associated with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Meningoencephalitis has recently been suggested to be a clinical finding typical of myelin oligodendrocyte glycoprotein (MOG) encephalomyelitis. We report a Chinese patient with recurrent ON at disease initiation, who had a delayed diagnosis of MOG-IgG syndrome, until recurrent meningoencephalitis appeared and serum MOG-IgG was detected. Case presentation: From the age of 7 years, an AQP4-IgG negative female patient had 10 disease recurrences, including 4 episodes of recurrent ON, 4 episodes of fever and meningoencephalitis, and 2 episodes of ON as well as meningoencephalitis. She was initially diagnosed as recurrent ON and treated with glucocorticoids followed by gradual tapering when ON reoccurred. Later, she was diagnosed as central nervous system infection when fever and meningoencephalitis appeared, and antiviral drugs and glucocorticoids were used. However, when she returned to our department for follow-up on July 2017, the results of serum demyelinating autoimmune antibody revealed positive MOG-IgG (titer 1:320 by an in-house, cell-based assay using live cells transfected with full-length human MOG). A diagnosis of MOG-IgG syndrome was established. Conclusions: Testing for MOG-IgG in atypical MS and NMOSD patients, and patients with meningoencephalitis with a history of relapsing demyelinating symptoms is warranted.

Original languageEnglish
Article number94
Pages (from-to)490-490
JournalBMC Neurology
Volume19
Issue number1
DOIs
Publication statusPublished - 9 May 2019

Fingerprint

Myelin-Oligodendrocyte Glycoprotein
Optic Neuritis
Meningoencephalitis
Delayed Diagnosis
Immunoglobulin G
Neuromyelitis Optica
Glucocorticoids
Multiple Sclerosis
Fever
Encephalomyelitis
Central Nervous System Infections
Serum
Antiviral Agents
Recurrence
Antibodies

Cite this

Zhong, Xiaonan ; Chang, Yanyu ; Tan, Sha ; Wang, Jingqi ; Sun, Xiaobo ; Wu, Aimin ; Peng, Lisheng ; Lau, Alexander Y. ; Kermode, Allan G. ; Qiu, Wei. / Relapsing optic neuritis and meningoencephalitis in a child : Case report of delayed diagnosis of MOG-IgG syndrome. In: BMC Neurology. 2019 ; Vol. 19, No. 1. pp. 490-490.
@article{bd1c376a2f5b4a5ebb6340073bcf8754,
title = "Relapsing optic neuritis and meningoencephalitis in a child: Case report of delayed diagnosis of MOG-IgG syndrome",
abstract = "Background: Recurrent optic neuritis (ON) was previously thought to be associated with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Meningoencephalitis has recently been suggested to be a clinical finding typical of myelin oligodendrocyte glycoprotein (MOG) encephalomyelitis. We report a Chinese patient with recurrent ON at disease initiation, who had a delayed diagnosis of MOG-IgG syndrome, until recurrent meningoencephalitis appeared and serum MOG-IgG was detected. Case presentation: From the age of 7 years, an AQP4-IgG negative female patient had 10 disease recurrences, including 4 episodes of recurrent ON, 4 episodes of fever and meningoencephalitis, and 2 episodes of ON as well as meningoencephalitis. She was initially diagnosed as recurrent ON and treated with glucocorticoids followed by gradual tapering when ON reoccurred. Later, she was diagnosed as central nervous system infection when fever and meningoencephalitis appeared, and antiviral drugs and glucocorticoids were used. However, when she returned to our department for follow-up on July 2017, the results of serum demyelinating autoimmune antibody revealed positive MOG-IgG (titer 1:320 by an in-house, cell-based assay using live cells transfected with full-length human MOG). A diagnosis of MOG-IgG syndrome was established. Conclusions: Testing for MOG-IgG in atypical MS and NMOSD patients, and patients with meningoencephalitis with a history of relapsing demyelinating symptoms is warranted.",
keywords = "Demyelinating disease, Meningoencephalitis, MOG-IgG",
author = "Xiaonan Zhong and Yanyu Chang and Sha Tan and Jingqi Wang and Xiaobo Sun and Aimin Wu and Lisheng Peng and Lau, {Alexander Y.} and Kermode, {Allan G.} and Wei Qiu",
year = "2019",
month = "5",
day = "9",
doi = "10.1186/s12883-019-1324-4",
language = "English",
volume = "19",
pages = "490--490",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",
number = "1",

}

Zhong, X, Chang, Y, Tan, S, Wang, J, Sun, X, Wu, A, Peng, L, Lau, AY, Kermode, AG & Qiu, W 2019, 'Relapsing optic neuritis and meningoencephalitis in a child: Case report of delayed diagnosis of MOG-IgG syndrome' BMC Neurology, vol. 19, no. 1, 94, pp. 490-490. https://doi.org/10.1186/s12883-019-1324-4

Relapsing optic neuritis and meningoencephalitis in a child : Case report of delayed diagnosis of MOG-IgG syndrome. / Zhong, Xiaonan; Chang, Yanyu; Tan, Sha; Wang, Jingqi; Sun, Xiaobo; Wu, Aimin; Peng, Lisheng; Lau, Alexander Y.; Kermode, Allan G.; Qiu, Wei.

In: BMC Neurology, Vol. 19, No. 1, 94, 09.05.2019, p. 490-490.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relapsing optic neuritis and meningoencephalitis in a child

T2 - Case report of delayed diagnosis of MOG-IgG syndrome

AU - Zhong, Xiaonan

AU - Chang, Yanyu

AU - Tan, Sha

AU - Wang, Jingqi

AU - Sun, Xiaobo

AU - Wu, Aimin

AU - Peng, Lisheng

AU - Lau, Alexander Y.

AU - Kermode, Allan G.

AU - Qiu, Wei

PY - 2019/5/9

Y1 - 2019/5/9

N2 - Background: Recurrent optic neuritis (ON) was previously thought to be associated with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Meningoencephalitis has recently been suggested to be a clinical finding typical of myelin oligodendrocyte glycoprotein (MOG) encephalomyelitis. We report a Chinese patient with recurrent ON at disease initiation, who had a delayed diagnosis of MOG-IgG syndrome, until recurrent meningoencephalitis appeared and serum MOG-IgG was detected. Case presentation: From the age of 7 years, an AQP4-IgG negative female patient had 10 disease recurrences, including 4 episodes of recurrent ON, 4 episodes of fever and meningoencephalitis, and 2 episodes of ON as well as meningoencephalitis. She was initially diagnosed as recurrent ON and treated with glucocorticoids followed by gradual tapering when ON reoccurred. Later, she was diagnosed as central nervous system infection when fever and meningoencephalitis appeared, and antiviral drugs and glucocorticoids were used. However, when she returned to our department for follow-up on July 2017, the results of serum demyelinating autoimmune antibody revealed positive MOG-IgG (titer 1:320 by an in-house, cell-based assay using live cells transfected with full-length human MOG). A diagnosis of MOG-IgG syndrome was established. Conclusions: Testing for MOG-IgG in atypical MS and NMOSD patients, and patients with meningoencephalitis with a history of relapsing demyelinating symptoms is warranted.

AB - Background: Recurrent optic neuritis (ON) was previously thought to be associated with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Meningoencephalitis has recently been suggested to be a clinical finding typical of myelin oligodendrocyte glycoprotein (MOG) encephalomyelitis. We report a Chinese patient with recurrent ON at disease initiation, who had a delayed diagnosis of MOG-IgG syndrome, until recurrent meningoencephalitis appeared and serum MOG-IgG was detected. Case presentation: From the age of 7 years, an AQP4-IgG negative female patient had 10 disease recurrences, including 4 episodes of recurrent ON, 4 episodes of fever and meningoencephalitis, and 2 episodes of ON as well as meningoencephalitis. She was initially diagnosed as recurrent ON and treated with glucocorticoids followed by gradual tapering when ON reoccurred. Later, she was diagnosed as central nervous system infection when fever and meningoencephalitis appeared, and antiviral drugs and glucocorticoids were used. However, when she returned to our department for follow-up on July 2017, the results of serum demyelinating autoimmune antibody revealed positive MOG-IgG (titer 1:320 by an in-house, cell-based assay using live cells transfected with full-length human MOG). A diagnosis of MOG-IgG syndrome was established. Conclusions: Testing for MOG-IgG in atypical MS and NMOSD patients, and patients with meningoencephalitis with a history of relapsing demyelinating symptoms is warranted.

KW - Demyelinating disease

KW - Meningoencephalitis

KW - MOG-IgG

UR - http://www.scopus.com/inward/record.url?scp=85065467337&partnerID=8YFLogxK

U2 - 10.1186/s12883-019-1324-4

DO - 10.1186/s12883-019-1324-4

M3 - Article

VL - 19

SP - 490

EP - 490

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

IS - 1

M1 - 94

ER -